Insiders · Profile

Tammenoms Bakker Juliet

Director at Ceribell · Director at RxSight. Filing since 3 Aug 2021. CIK 0001431159

Company
Date
Role
Action
Shares
Amount
Of holding
15 Oct 2024
Director
Bought
237,234
$4.03M
10.6%
17 May 2024
Director
Bought
5,000
$305.46K
16.8%
14 Feb 2024
Director
Bought
4,000
$205.15K
15.5%
12 Feb 2024
Director
Bought
4,000
$201.52K
18.3%
29 Nov 2023
Director
Sold at will
349,245
$10.40M
100%
28 Nov 2023
Director
Sold at will
145,068
$4.30M
29.3%
15 Nov 2023
Director
Sold at will
400,000
$10.88M
44.7%
14 Nov 2023
Director
Sold at will
100,000
$2.71M
10.1%
11 Sep 2023
Director
Sold at will
2,950
$88.52K
12.7%
8 Sep 2023
Director
Sold at will
10,033
$303.46K
30.2%
7 Sep 2023
Director
Sold at will
19,967
$600.98K
37.6%
25 Aug 2023
Director
Sold at will
16,208
$474.13K
23.4%
18 Aug 2023
Director
Sold at will
14,651
$425.88K
17.6%
17 Aug 2023
Director
Sold at will
18,484
$555.69K
18.2%
10 Feb 2023
Director
Bought
480,000
$6.00M
96.0%
3 Aug 2021
Director
Bought
625,000
$10.00M
45.8%
3 Aug 2021
Director
Bought
12,500
$200.00K
213%
17 decisions on file.